Seminars in Radiation Oncology
Volume 17, Issue 1 , Pages 38-44 , January 2007

Are Squamous and Adenocarcinomas of the Esophagus the Same Disease?

  • J. Rüdiger Siewert, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to J. Rüdiger Siewert, MD, Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaningerstr. 22, Munich, Germany 81675.
    • ,
  • Katja Ott, MD

References 

  1. Wu X, Gu J, Wu TT, et al. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006;24(23):3789–3798
  2. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, disease-free survival, and outcome: A plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962–972
  3. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360–367
  4. Mariette C, Finzi L, Piessen G, et al. Esophageal carcinoma: Prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg. 2005;29:39–45
  5. Alexandrou A, Davis PA, Law S, et al. Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences. Dis Esophagus. 2002;15:290–295
  6. Rohatgi PR, Swisher SG, Correa AM, et al. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer. 2006;106:552–558
  7. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  8. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289
  9. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85–92
  10. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–1413
  11. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–155
  12. Mariette C, Triboulet JP. Is preoperative chemoradiation effective in treatment of oesophageal carcinoma?. Lancet Oncol. 2005;6:635–637
  13. Koppert LB, Janssen-Heijnen ML, Louwman MW, et al. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: A population-based study. Eur J Gastroenterol Hepatol. 2004;16:681–688
  14. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: Relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139–146
  15. Meining A, Ott R, Becker I, et al. The Munich Barrett follow up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only—What is the clinical significance?. Gut. 2004;53:1402–1407
  16. Siewert JR, Feith M, Stein HJ. Esophagectomy as therapeutie principle for squamous cell esophageal cancer. Chirurg. 2005;76:1033–1043
  17. Siewert JR, Bartels H, Stein HJ. Abdomino-right-thoracic esophagectomy with intrathoracic anastomosis in Barrett’s cancer. Chirurg. 2005;76:588–594
  18. Siewert JR, Stein HJ, Feith M. Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett’s cancer). World J Surg. 2003;27:1058–1061
  19. Abunasra H, Lewis S, Beggs L, et al. Predictors of operative death after oesophagectomy for carcinoma. Br J Surg. 2005;92:1029–1033
  20. Lerut T, De LP, Coosemans W, et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg. 1992;216:583–590
  21. Lund O, Hasenkam JM, Aagaard MT, et al. Time-related changes in characteristics of prognostic significance in carcinomas of the oesophagus and cardia. Br J Surg. 1989;76:1301–1307
  22. Lieberman MD, Shriver CD, Bleckner S, et al. Carcinoma of the esophagus (Prognostic significance of histologic type). J Thorac Cardiovasc Surg. 1995;109:130–138
  23. Skinner DB, Dowlatshahi KD, DeMeester TR. Potentially curable cancer of the esophagus. Cancer. 1982;50:2571–2575
  24. Holscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer (Comparison between adeno- and squamous cell carcinoma). Cancer. 1995;76:178–186
  25. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: Pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–573
  26. Bollschweiler E, Baldus SE, Schroder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38:149–156
  27. Chibana Y, Fujii S, Ichikawa K, et al. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. J Gastroenterol Hepatol. 2005;20:1371–1378
  28. Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–1085
  29. von Rahden BH, Stein HJ, Feith M, et al. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2005;23:874–879
  30. Kuwano H, Kato H, Miyazaki T, et al. Genetic alterations in esophageal cancer. Surg Today. 2005;35:7–18
  31. Kuwano H. Peculiar histopathologic features of esophageal cancer. Surg Today. 1998;28:573–575
  32. Kuwano H, Saeki H, Kawaguchi H, et al. Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous-cell carcinoma. Int J Cancer. 1998;78:149–152
  33. Lordick F, Stein HJ, Peschel C, et al. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg. 2004;91:540–551
  34. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol. 2001;19:3058–3065
  35. Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23:4330–4337
  36. Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography. Ann Surg. 2001;233:300–309
  37. Brucher BL, Stein HJ, Zimmermann F, et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: Results of a prospective phase-II trial. Eur J Surg Oncol. 2004;30:963–971
  38. Wieder HA, Brucher BL, Zimmermann F, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol. 2004;22:900–908
  39. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91:2165–2174
  40. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol. 2001;19:3058–3065
  41. Heidecke CD, Weighardt H, Feith M, et al. Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery. 2002;132:495–501
  42. Hulscher JB, van Lanschot JJ. Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction. Dig Surg. 2005;22:130–134

PII: S1053-4296(06)00079-8

doi: 10.1016/j.semradonc.2006.09.007

Seminars in Radiation Oncology
Volume 17, Issue 1 , Pages 38-44 , January 2007

Article Tools

* Image Usage & Resolution